The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes
Type 2 diabetes mellitus (T2D) is a slowly progressive disease that can be postponed or even avoided through lifestyle changes. Recent data demonstrate highly significant correlations between DNA methylation and the most important risk factors of T2D, including age and BMI, in blood and human tissue...
Main Authors: | Linn eGillberg, Charlotte eLing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00043/full |
Similar Items
-
Integration of datasets for individual prediction of DNA methylation-based biomarkers
by: Charlotte Merzbacher, et al.
Published: (2023-12-01) -
Highlight DNA Methylation Biomarkers in Different Cancer Type for Drug Designing
by: Samina Gul, et al.
Published: (2022-02-01) -
DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
by: Gregory Alexander Raciti, et al.
Published: (2021-10-01) -
The potential of DNA methylation markers in the study of obesity
by: A. F. Nikolaeva, et al.
Published: (2024-01-01) -
Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen
by: Maximilian Schmutz, et al.
Published: (2023-10-01)